Loading... Please wait...

Zymeworks Inc. (ZYME) Competitors

Currency in USD Disclaimer
$8.88 $0.49 (5.84%)
$8.33
$8.89
$6.02
$13.14
Symbol Company Share Price Market Cap P/E Ratio Employee Count revenue rating
Akero Therapeutics, Inc. $21.44 $1.59 B -7.1 58 $0
Alector, Inc. $4.41 $420.24 M -3.14 244 $97.06 M
Annexon, Inc. $4.50 $523.15 M -3.93 70 $0
Apellis Pharmaceuticals, Inc. $36.26 $4.90 B -11.77 702 $396.59 M
Arrowhead Pharmaceuticals, Inc. $25.56 $2.97 B -5.65 525 $240.74 M
bluebird bio, Inc. $0.92 $174.43 M -1.44 323 $3.60 M
Blueprint Medicines Corporation $111.64 $6.47 B -21.48 645 $249.38 M
Cabaletta Bio, Inc. $7.03 $508.83 M -6.16 118 $0
Cytokinetics, Incorporated $55.45 $6.05 B -9.78 423 $7.53 M
Day One Biopharmaceuticals, Inc. $13.71 $1.12 B -5.11 174 $0
Editas Medicine, Inc. $4.58 $435.86 M -2.56 265 $78.12 M
Inozyme Pharma, Inc. $4.49 $286.39 M -3.43 59 $0
Mersana Therapeutics, Inc. $1.83 $261.85 M -1.91 123 $36.86 M
ProQR Therapeutics N.V. $1.71 $151.08 M -5.14 156 $6.38 M
Protagonist Therapeutics, Inc. $33.71 $2.04 B 13.7 124 $60.00 M
Relay Therapeutics, Inc. $6.37 $1.05 B -3 309 $25.55 M
Revolution Medicines, Inc. $37.53 $6.66 B -10.51 411 $11.58 M
Syndax Pharmaceuticals, Inc. $20.93 $1.66 B -6.02 184 $0
Stoke Therapeutics, Inc. $13.12 $774.50 M -6.14 110 $8.78 M
Terns Pharmaceuticals, Inc. $6.82 $462.44 M -5.67 66 $0
Travere Therapeutics, Inc. $7.90 $542.80 M -1.32 380 $145.24 M
Y-mAbs Therapeutics, Inc. $11.38 $525.71 M -24.45 100 $84.82 M
Zentalis Pharmaceuticals, Inc. $3.63 $754.16 M -3.26 124 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.